title: The inflammatory response to cardiopulmonary bypass: part 2--anti-inflammatory therapeutic strategies.
authors.affiliation: Department of BioSurgery and Surgical Technology, Imperial College London, St Mary's Hospital, London, United Kingdom. o.warren@imperial.ac.uk
authors.forename: Oliver J
authors.initials: OJ
authors.lastname: Warren
authors.forename: Amy L
authors.initials: AL
authors.lastname: Watret
authors.forename: Katie L
authors.initials: KL
authors.lastname: de Wit
authors.forename: Christos
authors.initials: C
authors.lastname: Alexiou
authors.forename: Charles
authors.initials: C
authors.lastname: Vincent
authors.forename: Ara W
authors.initials: AW
authors.lastname: Darzi
authors.forename: Thanos
authors.initials: T
authors.lastname: Athanasiou
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D002986:Clinical Trials as Topic / Q000379:methods; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000209:etiology; D011183:Postoperative Complications / Q000188:drug therapy / Q000209:etiology; D012307:Risk Factors
chemical_list: D000893:Anti-Inflammatory Agents